CDK5 and hepatocellular carcinoma: We have previously shown that treatment of HUH7 tumors with roscovitine (rosco), a well-established CDK5 inhibitor [22], or downregulation of CDK5 by siRNA in HCC cells, causes reduction of tumor growth to about one half or less [6].